Calamos Advisors LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$177,394
-46.2%
14,746
-61.3%
0.00%0.0%
Q1 2022$330,000
-79.3%
38,071
-65.9%
0.00%
-83.3%
Q4 2021$1,593,000
-45.2%
111,519
-15.6%
0.01%
-53.8%
Q3 2021$2,906,000132,1450.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders